Office of Personnel Management
Executive Summary
Pfizer, Merck and Parke-Davis (now part of Pfizer) refused to supply pharmaceuticals at Federal Supply Schedule prices for Special Agents Mutual Benefit Association Health Plan mail-order prescriptions, resulting in OMB calling off the pilot project. Started in June, the goal of the pilot program was to determine whether FSS prices should be extended to all Federal Employee Health Benefits Program plans (1"The Pink Sheet" June 19, p. 13). Merck-Medco is the pharmacy benefit management company that administers the SAMBA plan
You may also be interested in...
FEHBP Premium "Call Letter" To Kick Off Hill Debate On Employee Program
The role of pharmaceutical prices in the cost of the Federal Employees Health Benefit Program will return as a Capitol Hill issue following the release of the Office of Personnel Management's annual "call letter" on FEHBP premiums in early April.
FEHBP Premium "Call Letter" To Kick Off Hill Debate On Employee Program
The role of pharmaceutical prices in the cost of the Federal Employees Health Benefit Program will return as a Capitol Hill issue following the release of the Office of Personnel Management's annual "call letter" on FEHBP premiums in early April.
FEHBP Pilot Program Will Use FSS Prices For 18,000 Enrollees
A Federal Employees Health Benefits Program pilot program will provide access to Federal Supply Schedule pharmaceutical prices for a small subset of enrollees, starting the week of June 19.